Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_provenance.
- NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_assertion description "[Therefore, targeting to the AMPA receptor subunit GluR2 can be considered a practical strategy for stroke therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_provenance.
- NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_assertion evidence source_evidence_literature NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_provenance.
- NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_assertion SIO_000772 16215279 NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_provenance.
- NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_assertion wasDerivedFrom befree-20150227 NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_provenance.
- NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_assertion wasGeneratedBy ECO_0000203 NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP433807.RAjpYwKF_2mcheHLVbUtM11-1n8va26SB4RJG26sMFwAg130_provenance.